MR
Merus
MRUS·NASDAQUtrecht NLFounded 2003400 employees
Mid CapbiotechPublicOncology
Platform: Biclonics
Market Cap
$4B
All Drugs
3
Clinical Trials
6
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (MRUS)
Loading MRUS stock data...
Drug Pipeline (3 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| MRU-8112 | MRU-8112 | Preclinical | 2 | PD-L1 | Huntington'sDMD | ||
| Rimanesiran | MRU-5611 | Phase 1 | 1 | TIM-3 | RSV | ||
| MRU-1869 | MRU-1869 | Approved | 3 | GPRC5D | RB |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (6)